Pharmacovigilance Market By Type (Spontaneous Reporting, Targeted Spontaneous Reporting, Intensified ADR Reporting, EHR Mining, and Cohort Event Monitoring), By Life Cycle (Phase IV, Phase III, Phase II, Phase I, and Pre-clinical), By Service Provider (Contract Outsourcing and In-house), By Application (Oncology, Respiratory Systems, Neurology, Cardiology, and Others), By Process Flow (Signal Detection (Adverse Event Review & Reporting, Adverse Event Logging, and Adverse Event Analysis), Case Data Management (Case Data Analysis and Case Logging), Medical Reviewing & Reporting, and Risk Management System (Risk Mitigation System and Risk Evaluation System)), By End-user (Pharmaceuticals, Medical Device Manufacturers, Biotechnology Companies, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034